Literature DB >> 26466645

Protective effects of sesamin on liver fibrosis through antioxidative and anti-inflammatory activities in rats.

Xiaowei Chen1, Xiaozhou Ying2, Lu Chen3, Weiwei Zhang4, Youcai Zhang3.   

Abstract

CONTEXT: Sesamin (Ses) from Sesamun indicum seeds has potent antioxidants and anti-inflammatory effects.
OBJECTIVE: This study focused on the antioxidant and anti-inflammatory effects of Ses on Carbon tetrachloride (CCl4)-induced hepatic fibrosis in experimental rats and the potential mechanism underlying the activation of NF-kB pathway.
MATERIALS AND METHODS: Hepatic fibrosis was induced by interaperitoneally (i.p.) administered with 20% CCl4 in corn oil (2 mL/kg for 8 weeks) in rats. After 8 weeks, activities of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin (TBIL) were checked. The levels of protein carbonyls and antioxidant enzymes such as superoxide dismutase (SOD) and GSH-Px were determined after Ses administration. H&E and Masson's trichrome staining for histopathological changes of liver tissues were observed. Western blotting was used to detect expression of IL-6, cyclooxygenase-2 (COX-2), and NF-kB activation. Finally, the levels of hydroxyproline in liver tissues were also determined.
RESULTS: Ses decreased the release of liver enzymes - ALT, AST, and TBIL, reduced protein carbonyls, attenuated the reduction of SOD and GSH-Px activities induced by CCl4 in the liver tissue. It also significantly reduced the levels IL-6 and COX-2 in the liver caused by CCl4 by inhibition of NF-kB activation. Histological results indicated that Ses significantly improved the pathological lesions of liver fibrosis.
CONCLUSIONS: Ses exerted hepatoprotective effects possibly due to the antioxidant effect and suppressing the NF-kB activation.

Entities:  

Keywords:  Anti-inflammatory; NF-kB; antioxidant; hepatic fibrosis; sesamin

Mesh:

Substances:

Year:  2015        PMID: 26466645     DOI: 10.3109/08923973.2015.1085064

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  6 in total

1.  Annexin A1 accounts for an anti-inflammatory binding target of sesamin metabolites.

Authors:  Yasuaki Kabe; Daisuke Takemoto; Ayaka Kanai; Miwa Hirai; Yoshiko Ono; Sota Akazawa; Manabu Horikawa; Yoshinori Kitagawa; Hiroshi Handa; Tomohiro Rogi; Hiroshi Shibata; Makoto Suematsu
Journal:  NPJ Sci Food       Date:  2020-02-20

2.  The impact of Lactobacillus acidophilus on hepatic and colonic fibrosis induced by ethephon in a rat model.

Authors:  Hoda I Bahr; Rania Hamad; Shimaa Aa Ismail
Journal:  Iran J Basic Med Sci       Date:  2019-08       Impact factor: 2.699

3.  Annexin A1 accounts for an anti-inflammatory binding target of sesamin metabolites.

Authors:  Yasuaki Kabe; Daisuke Takemoto; Ayaka Kanai; Miwa Hirai; Yoshiko Ono; Sota Akazawa; Manabu Horikawa; Yoshinori Kitagawa; Hiroshi Handa; Tomohiro Rogi; Hiroshi Shibata; Makoto Suematsu
Journal:  NPJ Sci Food       Date:  2020-02-20

Review 4.  Sesame (Sesamum indicum L.): A Comprehensive Review of Nutritional Value, Phytochemical Composition, Health Benefits, Development of Food, and Industrial Applications.

Authors:  Panpan Wei; Fenglan Zhao; Zhen Wang; Qibao Wang; Xiaoyun Chai; Guige Hou; Qingguo Meng
Journal:  Nutrients       Date:  2022-09-30       Impact factor: 6.706

5.  The Protective Effects of Sesamin against Cyclophosphamide-Induced Nephrotoxicity through Modulation of Oxidative Stress, Inflammatory-Cytokines and Apoptosis in Rats.

Authors:  Saeed Alshahrani; Hani M Ali Thubab; Abdulrahman M Ali Zaeri; Tarique Anwer; Rayan A Ahmed; Abdulmajeed M Jali; Marwa Qadri; Yousra Nomier; Sivakumar S Moni; Mohammad F Alam
Journal:  Int J Mol Sci       Date:  2022-10-01       Impact factor: 6.208

6.  Self-Nanoemulsifying Drug Delivery Systems for Enhancing Solubility, Permeability, and Bioavailability of Sesamin.

Authors:  Chih-Yuan Wang; Ching-Chi Yen; Mei-Chich Hsu; Yu-Tse Wu
Journal:  Molecules       Date:  2020-07-08       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.